LMR Partners’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
MF
SCM
CL
AA
PAMP
LA
TCM
LMR Partners's TDACW Position: Q1 2026 in Review
LMR Partners held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 400,000 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #1311.
LMR Partners first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $124K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.
- LMR Partners held 400,000 shares of Translational Development Acquisition Corp Warrants worth $48K as of Q1 2026.
- LMR Partners left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1311 holding.
- LMR Partners first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
- LMR Partners's Translational Development Acquisition Corp Warrants position peaked at $124K in Q4 2025.
- 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.